J. Tabernero
发表
E. Felip,
S. Choo,
J. Haanen,
2021,
ESMO Open.
N. Isambert,
Y. Silber,
R. Fritsch,
2022,
ESMO open.
E. Van Cutsem,
M. Ducreux,
A. de Gramont,
2022,
ESMO open.
R. Labianca,
R. Salazar,
P. Laurent-Puig,
2020,
Annals of oncology : official journal of the European Society for Medical Oncology.
I. Melero,
J. Blay,
M. Maio,
2022,
ESMO open.
P. Jänne,
P. Ascierto,
P. V. Van Schil,
2020,
Annals of Oncology.
J. Nolla,
S. Castañeda,
E. Loza,
2015
.
A. Schram,
I. Braña,
P. Vickers,
2022,
ESMO open.
R. Dienstmann,
T. Troiani,
I. Puig,
2023,
ESMO open.
I. Baraibar,
J. Ros,
J. Tabernero,
2023,
ESMO open.
M. Provencio,
Á. Rodríguez-Lescure,
P. Garrido,
2021,
Clinical and Translational Oncology.
J. Berlin,
K. Haustermans,
P. Laurent-Puig,
2023,
ESMO open.
DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype.
M. Fraga,
P. Nuciforo,
I. Puig,
2023,
Cell reports.
Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity.
I. Carrió,
M. Estorch,
L. Bernà,
1995,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
A. M. Cavalheiro,
H. S. King,
H. Z. Chai,
2016,
Intensive care medicine experimental.
A. M. Cavalheiro,
H. S. King,
M. M. Moraes,
2016,
Intensive Care Medicine Experimental.
J. Tabernero,
I. Braña,
J. Tabernero,
2010,
Annals of oncology : official journal of the European Society for Medical Oncology.